Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.65 AUD | -2.26% | +9.24% | +27.45% |
16/04 | Euroz Hartleys Adjusts Argenica Therapeutics’ Price Target to AU$1.40 From AU$1.50, Keeps at Speculative Buy | MT |
12/04 | Argenica Therapeutics Raises AU$12 Million via Placement | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
+27.45% | 53.96M | |
+29.34% | 48.16B | |
-0.40% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.97% | 25.59B | |
-22.69% | 18.96B | |
+9.20% | 12.92B | |
+30.09% | 12.03B | |
-1.65% | 11.77B |
- Stock Market
- Equities
- AGN Stock
- News Argenica Therapeutics Limited
- Argenica Therapeutics On Track for First Patient Dosing in Phase 2 ARG-007 Trial in Q1 2024